Immunai - Immune Profiling Platform Software
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel discoveries.
-
Most popular related searches
The Opportunity
The immune system is central to human disease and health
When it functions correctly, it fights off infections; When it is overactive, it can lead to autoimmune disease; When it becomes dysfunctional, cancer can take hold.
Immunotherapies are a class of therapeutics that modulate the immune system to fight disease - For cancer patients, immunotherapies can deliver miracles when they work.
There are currently many immunotherapies in development. However, understanding their future impact on patients remains a challenge due to the tremendous complexity of the immune system - What we don’t know still far outweighs what we do.
If we can characterize the immune system at a deep level of granularity and consistency, we can unlock insights that will dramatically enhance our understanding of health, disease and therapeutic development. For cancer and well beyond.
Immunai’s immune profiling platform
Immunai combines comprehensive, multi-omic single cell genomics with cutting edge machine learning algorithms to enable high resolution profiling of the immune system, at industrial scale, with rapid turnaround.
Immunai’s end to end platform is generating the world’s largest knowledge base of high granularity immunological data.
Our goal is to decode the immune system, and use this knowledge to unlock biological insights that:
Accelerate
clinical trials and avoid costly failures
Improve efficacy
of immunotherapies and combinations
Power
the next generation of therapeutics
Immunai’s Advantage
Better Data
Multi-omic single cell biological assays
consistently executed protocols for single cell immunology
Functional genomic screens
refined with machine learning algorithms
Advanced data integration
and bioinformatics infrastructure
Dependable, consistently curated single cell data
from both clinical trials and public literature
Better Analysis
Machine Learning
incorporated as core architecture
Differentiate
between cell subtypes and substates at hypergranular resolution
Identify rare cell types
and longitudinally track clonal expansion and phenotypic change
Batch
harmonization enabling analysis at scale
Better Insights
- Characterize immune mechanisms of response and resistance
- Data-driven design of synergistic immunotherapy combinations
- Measure immune response as a surrogate endpoint for clinical response
- Discover predictive markers of response or resistance
- Measure heterogeneity in CAR T cell therapy product
- Identify rare cell subtypes or sub-states that correlate with outsized clinical effect
Solutions
Our platform is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines.
We partner with academic research institutions, biopharmaceutical players, and biotechs to explore new indications and additional high value applications of our technology and data.
Customer reviews
No reviews were found for Immunai - Immune Profiling Platform Software. Be the first to review!